Skip to content

Effect of renal specific vitamins and minerals supplementation (KVITAL) on the nutritional status and psychological wellbeing of the Haemodialysis patient: pilot study

Effect of renal specific vitamins and minerals supplementation (KVITAL) on the nutritional status and psychological wellbeing of the Haemodialysis patient: pilot study

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12614000724673
Enrollment
42
Registered
2014-07-08
Start date
2014-08-01
Completion date
2014-08-19
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Assess whether routine vitamins supplementation, that is appropriate for Chronic Kidney Disease (Kidney Vital) improves patients nutritional status and quality of life.

Interventions

Assess whether routine vitamins supplementation, using a brand of vitamins formulation that is appropriate for Chronic Kidney Disease (Kidney Vital) improves patients nutritional status and quality of life. One tablet to be taken daily, orally for 6 months Active Ingredients and doses outlined below. Ascorbic acid 60 mg Biotin 30 microgram Calcium pantothenate 5 mg Cholecalciferol .025 mg Copper gluconate 900 microgram Cyanocobalamin 2.4 microgram Ferrous fumarate 8 mg Folic acid 400 microgram

Assess whether routine vitamins supplementation, using a brand of vitamins formulation that is appropriate for Chronic Kidney Disease (Kidney Vital) improves patients nutritional status and quality of life. One tablet to be taken daily, orally for 6 months Active Ingredients and doses outlined below. Ascorbic acid 60 mg Biotin 30 microgram Calcium pantothenate 5 mg Cholecalciferol .025 mg Copper gluconate 900 microgram Cyanocobalamin 2.4 microgram Ferrous fumarate 8 mg Folic acid 400 microgram Nicotinic acid 20 mg Pyridoxine hydrochloride 10 mg Riboflavin 2 mg Sodium selenate 55 microgram Thiamine nitrate 1.5 mg Zinc oxide Vitamin levels will be monitored with pathology testing, pre study and post commencement of study. Patients will be given a SF-36 Quality of life questionnaire and Subjective Global Assessment pre and post commencment of study to enstablish patient nutritional and psychological wellbeing. Patients will be educated on the benefits of taking a daily vitamin supplement to their nutritional status and well being.

Sponsors

Frankston Hospital Department of Medicine- Renal
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Chronic Kidney Disease stage 5 currently on haemodialysis at selected satellite unit

Exclusion criteria

Unable to comply to taking vitamin tablet daily for six month period of study

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026